Applied DNA Sciences, Inc.

BNB Plus Corp. provides digital asset treasury services, including real-time tracking of treasury performance and market indicators. Through its subsidiaries, it also develops and commercializes technologies for producing and detecting DNA and RNA across the Americas, Europe, Asia, and internationally. Its activities include enzymatic manufacture of synthetic DNA for nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, such as LineaDNA, LineaRNAP, and LineaIVT, along with the development and sale of a proprietary RNAP for mRNA therapeutic production. Formerly known as Applied DNA Sciences, Inc., the company changed its name to BNB Plus Corp. in November 2025, was founded in 1983, and is based in Stony Brook, New York.